|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 47/68 | (2017.01) |
| A61P 39/00 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| C07D 487/04 | (2006.01) | ||
| C07D 519/00 | (2006.01) |
| (11) | Number of the document | 2906248 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13780099.1 |
| Date of filing the European patent application | 2013-10-11 | |
| (97) | Date of publication of the European application | 2015-08-19 |
| (45) | Date of publication and mention of the grant of the patent | 2018-12-05 |
| (46) | Date of publication of the claims translation | 2019-02-11 |
| (86) | Number | PCT/EP2013/071235 |
| Date | 2013-10-11 |
| (87) | Number | WO 2014/057073 |
| Date | 2014-04-17 |
| (30) | Number | Date | Country code |
| 201261712924 P | 2012-10-12 | US |
| (72) |
HOWARD, Philip Wilson, GB
|
| (73) |
MedImmune Limited,
Milstein Building Granta Park, Cambridge CB21 6GH,
GB
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Pirolobenzodiazepinai ir jų konjugatai |
| PYRROLOBENZODIAZEPINES AND CONJUGATES THEREOF |
| Payment date | Validity (years) | Amount | |
| 2025-09-23 | 13 | 289.00 EUR |
| 2026-10-11 |